Authors: Astuti, D Agathanggelou, A Honorio, S Dallol, A Martinsson, T Kogner, P Cummins, C Neumann, HPH Voutilainen, R Dahia, P Eng, C Maher, ER Latif, F

Citation: D. Astuti et al., RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours, ONCOGENE, 20(51), 2001, pp. 7573-7577

Authors: Clifford, SC Astuti, D Hooper, L Maxwell, PH Ratcliffe, PJ Maher, ER

Citation: Sc. Clifford et al., The pVHL-associated SCF ubiquitin ligase complex: Molecular genetic analysis of elongin B and C, Rbx1 and HIF-1 alpha in renal cell carcinoma, ONCOGENE, 20(36), 2001, pp. 5067-5074

Authors: Astuti, D Douglas, F Lennard, TWJ Aligianis, IA Woodward, ER Evans, DGR Eng, C Latif, F Maher, ER

Citation: D. Astuti et al., Germline SDHD mutation in familial phaeochromocytoma, LANCET, 357(9263), 2001, pp. 1181-1182

Authors: Morrissey, C Martinez, A Zatyka, M Agathanggelou, A Honorio, S Astuti, D Morgan, NV Moch, H Richards, FM Kishida, T Yao, M Schraml, P Latif, F Maher, ER

Citation: C. Morrissey et al., Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma, CANCER RES, 61(19), 2001, pp. 7277-7281

Authors: Astuti, D Latif, F Dallol, A Dahia, PLM Douglas, F George, E Skoldberg, F Husebye, ES Eng, C Maher, ER

Citation: D. Astuti et al., Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma, AM J HU GEN, 69(1), 2001, pp. 49-54

Authors: Woodward, ER Clifford, SC Astuti, D Affara, NA Maher, ER

Citation: Er. Woodward et al., Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes, J MED GENET, 37(5), 2000, pp. 348-353